4.7 Article

Bioactive Triterpenes of Protium heptaphyllum Gum Resin Extract Display Cholesterol-Lowering Potential

期刊

出版社

MDPI
DOI: 10.3390/ijms22052664

关键词

hypercholesterolemia; gene expression; HMGCR; PCSK9; PPARα enzymatic activity; molecular docking; statin; monacolin; breu branco

资金

  1. Ph.D Program in Chemical and Material Sciences of the University of Turin
  2. company Abel Nutraceuticals S.R.L. (Turin, Italy)
  3. company Biosfered S.R.L. (Turin, Italy)

向作者/读者索取更多资源

The study demonstrates the potential of Protium heptaphyllum gum resin extract as an alternative to combat hypercholesterolemia, highlighting its role as a sustainable multitarget natural extract for the nutraceutical industry. Through chemical characterization, human hepatocyte studies, and molecular docking, it was found that PHE can reduce cholesterol production and regulate the expression of proteins involved in cholesterol metabolism.
Hypercholesterolemia is one of the major causes of cardiovascular disease, the risk of which is further increased if other forms of dyslipidemia occur. Current therapeutic strategies include changes in lifestyle coupled with drug administration. Statins represent the most common therapeutic approach, but they may be insufficient due to the onset of resistance mechanisms and side effects. Consequently, patients with mild hypercholesterolemia prefer the use of food supplements since these are perceived to be safer. Here, we investigate the phytochemical profile and cholesterol-lowering potential of Protium heptaphyllum gum resin extract (PHE). Chemical characterization via HPLC-APCI-HRMS2 and GC-FID/MS identified 13 compounds mainly belonging to ursane, oleanane, and tirucallane groups. Studies on human hepatocytes have revealed how PHE is able to reduce cholesterol production and regulate the expression of proteins involved in its metabolism. (HMGCR, PCSK9, LDLR, FXR, IDOL, and PPAR). Moreover, measuring the inhibitory activity of PHE against HMGR, moderate inhibition was recorded. Finally, molecular docking studies identified acidic tetra- and pentacyclic triterpenoids as the main compounds responsible for this action. In conclusion, our study demonstrates how PHE may be a useful alternative to contrast hypercholesterolemia, highlighting its potential as a sustainable multitarget natural extract for the nutraceutical industry that is rapidly gaining acceptance as a source of health-promoting compounds.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据